Making medicines evergreen

Developing a new drug costs less than $100m, not $900m

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f398 (Published 22 January 2013)
Cite this as: BMJ 2013;346:f398

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Peter C Gøtzsche, professor1
  1. 1Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark
  1. pcg{at}cochrane.dk

The popular myth created by the drug industry that it costs around $1bn (£0.63bn; €0.75bn) to develop a new drug never dies,1 although it has been refuted countless times. In reply to a BMJ paper mentioning this, Stephen Whitehead, chief executive, Association of the British Pharmaceutical Industry, claimed that the true cost was $1.6bn.2

These estimates are …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL